Conmed CNMD
NYSE CNMD
$46.99 +0.40 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Conmed (CNMD) EBT Margin Growth (3y) (2013 - 2026)

Analysis

Conmed (CNMD) EBT Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -429.00
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 803.00
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 260.00
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 574.00
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 764.00
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 835.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -1,045.00
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 598.00
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 423.00
10 Conmed 1.48 Bn 1.44 Bn 197.46 Mn 364.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 364.00
Mar 31, 2026 496.00
Dec 31, 2025 1,204.00
Sep 30, 2025 -445.00
Jun 30, 2025 4,246.00
Mar 31, 2025 -481.00
Dec 31, 2024 179.00
Sep 30, 2024 1,082.00
Jun 30, 2024 491.00
Mar 31, 2024 396.00
Dec 31, 2023 1,091.00
Sep 30, 2023 -64.00
Jun 30, 2023 2,623.00
Mar 31, 2023 -80.00
Dec 31, 2022 -1,071.00
Sep 30, 2022 167.00
Jun 30, 2022 -3,645.00
Mar 31, 2022 810.00
Dec 31, 2021 245.00
Sep 30, 2021 389.00